S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
Log in
NASDAQ:HGEN

Humanigen News Headlines

$18.63
+0.04 (+0.22 %)
(As of 03/1/2021 02:30 PM ET)
Add
Compare
Today's Range
$18.20
Now: $18.63
$19.42
50-Day Range
$17.22
MA: $19.55
$23.83
52-Week Range
$1.64
Now: $18.63
$33.95
Volume18,710 shs
Average Volume788,896 shs
Market Capitalization$961.62 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.79

Headlines

Humanigen (NASDAQ HGEN) News Headlines Today

Source:
SourceHeadline
Humanigen (NASDAQ:HGEN) Now Covered by JPMorgan Chase & Co.Humanigen (NASDAQ:HGEN) Now Covered by JPMorgan Chase & Co.
marketbeat.com - February 23 at 7:45 AM
Humanigen to Present at Multiple Investor Conferences in MarchHumanigen to Present at Multiple Investor Conferences in March
finance.yahoo.com - February 25 at 9:38 AM
Humanigen to Present at Multiple Investor Conferences in March - Business WireHumanigen to Present at Multiple Investor Conferences in March - Business Wire
businesswire.com - February 25 at 7:33 AM
Humanigen (NASDAQ:HGEN) Now Covered by Analysts at JPMorgan Chase & Co.Humanigen (NASDAQ:HGEN) Now Covered by Analysts at JPMorgan Chase & Co.
americanbankingnews.com - February 23 at 9:13 AM
UPDATE: JPMorgan Starts Humanigen (HGEN) at Neutral - StreetInsider.comUPDATE: JPMorgan Starts Humanigen (HGEN) at Neutral - StreetInsider.com
streetinsider.com - February 23 at 5:07 AM
7 Biotech Stocks Focused on Chronic Covid Treatment - InvestorPlace7 Biotech Stocks Focused on Chronic Covid Treatment - InvestorPlace
investorplace.com - February 22 at 1:49 PM
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020 - StreetInsider.comEmergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020 - StreetInsider.com
streetinsider.com - February 20 at 1:28 PM
Insider Selling: Humanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells 9,700 Shares of StockInsider Selling: Humanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells 9,700 Shares of Stock
americanbankingnews.com - February 19 at 7:18 PM
Bay Ltd. Nomis Sells 37,300 Shares of Humanigen, Inc. (NASDAQ:HGEN) StockBay Ltd. Nomis Sells 37,300 Shares of Humanigen, Inc. (NASDAQ:HGEN) Stock
americanbankingnews.com - February 19 at 6:32 PM
UPDATE 2-Vaccine manufacturing deals power Emergent BioSolutions profit beat - ReutersUPDATE 2-Vaccine manufacturing deals power Emergent BioSolutions profit beat - Reuters
reuters.com - February 19 at 7:10 AM
Vaccine manufacturing deals power Emergent BioSolutions profit beat - ReutersVaccine manufacturing deals power Emergent BioSolutions profit beat - Reuters
reuters.com - February 18 at 8:04 PM
Humanigen (NASDAQ:HGEN) Trading Up 8.4%Humanigen (NASDAQ:HGEN) Trading Up 8.4%
americanbankingnews.com - February 18 at 7:06 PM
Insider Selling: Humanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells 16,423 Shares of StockInsider Selling: Humanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells 16,423 Shares of Stock
americanbankingnews.com - February 17 at 12:40 AM
Humanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences - Business WireHumanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences - Business Wire
businesswire.com - February 11 at 7:38 AM
Humanigen to Present and Participate at Multiple Upcoming Investor and Industry ConferencesHumanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences
finance.yahoo.com - February 11 at 7:38 AM
Humanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells $367,052.40 in StockHumanigen, Inc. (NASDAQ:HGEN) Major Shareholder Sells $367,052.40 in Stock
americanbankingnews.com - February 10 at 6:28 PM
Bay Ltd. Nomis Sells 10,875 Shares of Humanigen, Inc. (NASDAQ:HGEN) StockBay Ltd. Nomis Sells 10,875 Shares of Humanigen, Inc. (NASDAQ:HGEN) Stock
americanbankingnews.com - February 10 at 6:28 PM
Humanigen Inc. (HGEN) Reports Election of Dr. Dale Chappell to Board - StreetInsider.comHumanigen Inc. (HGEN) Reports Election of Dr. Dale Chappell to Board - StreetInsider.com
streetinsider.com - February 8 at 12:09 PM
Humanigen Elects Dr. Dale Chappell to Board of DirectorsHumanigen Elects Dr. Dale Chappell to Board of Directors
finance.yahoo.com - February 8 at 9:19 AM
Humanigen Elects Dr. Dale Chappell to Board of Directors - Business WireHumanigen Elects Dr. Dale Chappell to Board of Directors - Business Wire
businesswire.com - February 8 at 7:08 AM
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing - Yahoo FinanceHumanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing - Yahoo Finance
finance.yahoo.com - February 5 at 6:22 PM
Bay Ltd. Nomis Sells 722 Shares of Humanigen, Inc. (NASDAQ:HGEN) StockBay Ltd. Nomis Sells 722 Shares of Humanigen, Inc. (NASDAQ:HGEN) Stock
americanbankingnews.com - February 4 at 10:19 PM
Bay Ltd. Nomis Sells 47,862 Shares of Humanigen, Inc. (NASDAQ:HGEN) StockBay Ltd. Nomis Sells 47,862 Shares of Humanigen, Inc. (NASDAQ:HGEN) Stock
americanbankingnews.com - February 4 at 9:32 PM
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing - Business WireHumanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing - Business Wire
businesswire.com - February 3 at 7:56 AM
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA FilingHumanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
finance.yahoo.com - February 3 at 7:56 AM
Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19
finance.yahoo.com - January 29 at 8:25 AM
Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19 - Business WireHumanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19 - Business Wire
businesswire.com - January 29 at 7:05 AM
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study - Business WireAjinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study - Business Wire
businesswire.com - January 28 at 5:45 PM
Ajinomoto and Humanigen expand manufacturing agreement for lenzilumab development - Seeking AlphaAjinomoto and Humanigen expand manufacturing agreement for lenzilumab development - Seeking Alpha
seekingalpha.com - January 27 at 6:00 PM
Emergent just struck another manufacturing deal. This one’s for an experimental Covid-19 therapy. - Washington Business JournalEmergent just struck another manufacturing deal. This one’s for an experimental Covid-19 therapy. - Washington Business Journal
bizjournals.com - January 27 at 1:00 PM
Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™ - Yahoo FinanceHumanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™ - Yahoo Finance
finance.yahoo.com - January 27 at 7:59 AM
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study - PRNewswireAjinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study - PRNewswire
prnewswire.com - January 27 at 7:59 AM
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 StudyAjinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
finance.yahoo.com - January 27 at 7:59 AM
Emergent Bio and Humanigen ink manufacturing agreement for COVID-19 candidate, lenzilumab - Seeking AlphaEmergent Bio and Humanigen ink manufacturing agreement for COVID-19 candidate, lenzilumab - Seeking Alpha
seekingalpha.com - January 26 at 8:12 AM
Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drug - MarketWatchHumanigen signs manufacturing deal with Emergent for experimental COVID-19 drug - MarketWatch
marketwatch.com - January 25 at 1:50 PM
Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drugHumanigen signs manufacturing deal with Emergent for experimental COVID-19 drug
finance.yahoo.com - January 25 at 1:24 PM
CytoDyn And Humanigen: Ticking Time Bombs, Impending Results Likely To Fail - Seeking AlphaCytoDyn And Humanigen: Ticking Time Bombs, Impending Results Likely To Fail - Seeking Alpha
seekingalpha.com - January 25 at 12:54 PM
Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™ - Business WireHumanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™ - Business Wire
businesswire.com - January 25 at 8:50 AM
Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™
finance.yahoo.com - January 25 at 8:50 AM
Form 8-K HUMANIGEN, INC For: Jan 21 - StreetInsider.comForm 8-K HUMANIGEN, INC For: Jan 21 - StreetInsider.com
streetinsider.com - January 22 at 2:22 PM
Humanigen Inc. (HGEN) Announces Addition of BARDA and Expansion of CRADA with US Government to Develop Lenzilumab for COVID-19 - StreetInsider.comHumanigen Inc. (HGEN) Announces Addition of BARDA and Expansion of CRADA with US Government to Develop Lenzilumab for COVID-19 - StreetInsider.com
streetinsider.com - January 22 at 2:22 PM
Stock Alert: Humanigen Trading 5% Higher - NasdaqStock Alert: Humanigen Trading 5% Higher - Nasdaq
nasdaq.com - January 22 at 2:22 PM
Humanigen expands its previous lenzilumab deal with U.S. government - Seeking AlphaHumanigen expands its previous lenzilumab deal with U.S. government - Seeking Alpha
seekingalpha.com - January 22 at 2:22 PM
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 - Yahoo FinanceHumanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 - Yahoo Finance
finance.yahoo.com - January 22 at 9:08 AM
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 - Business WireHumanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 - Business Wire
businesswire.com - January 22 at 7:18 AM
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19
finance.yahoo.com - January 22 at 7:18 AM
Daily Dividend Report: MMC,QCOM,DFS,CTAS,OGS - NasdaqDaily Dividend Report: MMC,QCOM,DFS,CTAS,OGS - Nasdaq
nasdaq.com - January 22 at 1:25 AM
Why Bionano Genomics Stock Is Down Today - NasdaqWhy Bionano Genomics Stock Is Down Today - Nasdaq
nasdaq.com - January 20 at 2:04 PM
Why Shares of AgEagle Aerial Systems Are Up Today - NasdaqWhy Shares of AgEagle Aerial Systems Are Up Today - Nasdaq
nasdaq.com - January 20 at 2:04 PM
Why Netflix Stock Jumped to an All-Time High Today - NasdaqWhy Netflix Stock Jumped to an All-Time High Today - Nasdaq
nasdaq.com - January 20 at 2:04 PM
Humanigen `panic selling is a buying opportunity, Jefferies says - Seeking AlphaHumanigen `panic selling' is a buying opportunity, Jefferies says - Seeking Alpha
seekingalpha.com - January 20 at 2:04 PM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.